Lv5
1080 积分 2021-12-09 加入
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study
22小时前
已完结
An evaluation of sugemalimab for the treatment of relapsed or refractory extranodal natural killer T-cell lymphoma
24天前
已完结
Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B‐Cell Lymphoma: A Real‐World, Multi‐Center, Retrospective Cohort Study
2个月前
已完结
Improved method to stratify lymphoma patients with risk of secondary central nervous system involvement: A multicenter retrospective analysis
2个月前
已完结
An evaluation of sugemalimab for the treatment of relapsed or refractory extranodal natural killer T-cell lymphoma
2个月前
已完结
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial
3个月前
已完结
Changes in Ki-67 in Residual Tumor and Outcome of Primary Inflammatory Breast Cancer Treated with Trimodality Therapy
4个月前
已完结
DLBCL: Who is high risk and how should treatment be optimized?
5个月前
已关闭
Marginal-Zone Lymphomas
7个月前
已完结
Ultra-low-dose radiation for gastric MALT lymphoma
7个月前
已完结
皖公网安备34019202002308
